<DOC>
<DOCNO>1051201_business_story_5543634.utf8</DOCNO>
<TEXT>


The Telegraph - Calcutta : Business

 ICRI arm ties up with British firm

 OUR SPECIAL CORRESPONDENT 

 Mumbai, Nov. 30: IRL, a subsidiary of the Institute of Clinical Research (India), has entered into a strategic alliance with Synexus Clinical Research plc. 

 Through this collaboration, IRL-Synexus will set up the countrys first patient-recruitment site management organisation to undertake phase II to phase IV of global clinical trials on new drugs.

 Synexus Clinical, based in the UK, is the largest patient recruitment organisation in Europe. IRL and Synexus have been undertaking clinical trials for pharmaceutical companies and contract research organisations. 

 Under the deal, IRL-Synexus will offer a chain of exclusive GCP-compliant investigator sites in India for fast and effective recruitment of patients and to deliver reliable, high quality data on schedule. Each IRL-Synexus Clinical Research centre will be equipped with GCP-trained staff comprising qualified doctors, nurses, data co-ordinators and administrators.

 India has the potential to become a preferred location for research and development for the global biotechnology and pharmaceutical sectors, said Shivraman Dugal, chairman of IRL.

 According to McKinsey, the global clinical trial outsourcing business in India is estimated be around Rs 5,000 crore by 2010. About 50,000 contract research professionals will be required, it added. 




</TEXT>
</DOC>